Jw (Cayman) Therapeutics
(OTC) JWCTF
Jw (Cayman) Therapeutics Financials at a Glance
Market Cap
$124.53M
Revenue (TTM)
$350.68M
Net Income (TTM)
$1.25B
EPS (TTM)
$-0.21
P/E Ratio
-1.47
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.31
Volume
300
Open
$0.31
Price
$0.31
Volume
300
Open
$0.31
Previous Close
$0.31
Daily Range
$0.31 - $0.31
52-Week Range
$0.16 - $0.66
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.31
Volume
300
Open
$0.31
Previous Close
$0.31
Daily Range
$0.31 - $0.31
52-Week Range
$0.16 - $0.66
JWCTF News
JWCTF: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Jw (Cayman) Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
281
CEO
MIn Liu, MBA
Website
www.jwtherapeutics.comHeadquarters
Shanghai, CN
JWCTF Financials
Key Financial Metrics (TTM)
Gross Margin
56%
Operating Margin
73%
Net Income Margin
-3%
Return on Equity
-52%
Return on Capital
14%
Return on Assets
-44%
Earnings Yield
-68.03%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$124.53M
Shares Outstanding
405.64M
Volume
300
Short Interest
0.00%
Avg. Volume
9.56K
Financials (TTM)
Gross Profit
$77.32M
Operating Income
$459.28M
EBITDA
$488.74M
Operating Cash Flow
$333.44M
Capital Expenditure
$15.43M
Free Cash Flow
$348.87M
Cash & ST Invst.
$757.38M
Total Debt
$422.40M
Jw (Cayman) Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$106.35M
+21.2%
Gross Profit
$65.12M
+45.3%
Gross Margin
61.23%
N/A
Market Cap
$124.53M
N/A
Market Cap/Employee
$443.17K
N/A
Employees
281
N/A
Net Income
$267.26M
+29.7%
EBITDA
$80.07M
+70.0%
Quarterly Fundamentals
Net Cash
$274.42M
-71.2%
Accounts Receivable
$25.05M
N/A
Inventory
$67.02M
+51.3%
Long Term Debt
$40.48M
-75.2%
Short Term Debt
$331.98M
+46.1%
Return on Assets
-43.51%
N/A
Return on Invested Capital
13.69%
N/A
Free Cash Flow
$0.00
+100.0%
Operating Cash Flow
$0.00
+100.0%